Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients

BACKGROUND: Immune checkpoint inhibitors (ICIs) have greatly improved the prognosis and overall management of non‐small cell lung cancer (NSCLC) patients, but in the long term less than 20% of patients benefit from treatment with ICIs. Therefore, it is necessary to guide the choice of immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Peng, Yang, Dongliang, Wang, Hanping, Cui, Xiaoxia, Si, Xiaoyan, Zhang, Xiaotong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262886/
https://www.ncbi.nlm.nih.gov/pubmed/32342665
http://dx.doi.org/10.1111/1759-7714.13447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262886/
https://www.ncbi.nlm.nih.gov/pubmed/32342665
http://dx.doi.org/10.1111/1759-7714.13447

Ejemplares similares